FDA Approves Mounjaro for Cardiovascular Risk Reduction in Type 2 Diabetes admin Setyembre 02, 2026 Add Comment Edit The FDA has approved Mounjaro for cardiovascular risk reduction in people with type 2 diabetes. Milko · E+/Getty The FDA ... Read More